FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to field of biotechnology of veterinary medications. Vaccine against rabies virus represents allantoic fluid of chicken embryos. Fluid contains glycoprotein of rabies virus, as well as mixture if recombinant adenoviruses of birds, which carry gene of surface glycoprotein of rabies virus, one of which contains secreted form of surface glycoprotein of rabies virus, and second - membrane-bound one. Interaction of glycoproteins with animal organism is reached by peroral introduction of medication.
EFFECT: invention can be applied in veterinary.
3 dwg, 1 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREPARATION OF RECOMBINANT BIRDS VIRUS FOR VACCINATION AND GENETIC THERAPY | 2007 |
|
RU2326942C1 |
| METHOD OF PREPARATION OF RECOMBINANT ADENOVIRUS OF BIRDS FOR VACCINATION AGAINST BIRDS FLU VIRUS H5N1 | 2006 |
|
RU2326943C1 |
| METHOD OF HUMAN RECOMBINANT LACTOFERRIN OBTAINING | 2007 |
|
RU2340674C1 |
| ANTI-FLU NANOANTIBODY, RECOMBINANT VIRAL VECTORS AND PHARMACEUTICAL COMPOSITIONS FOR PROPHYLAXIS AND THERAPY OF A-TYPE FLU | 2011 |
|
RU2502745C2 |
| RECOMBINANT NEWCASTLE DISEASE VIRUS EXPRESSING H5 HEMAGGLUTININ OF AVIAN INFLUENZA VIRUS | 2007 |
|
RU2441070C2 |
| IMMORTALISED BIRD CELL LINES FOR OBTAINING VIRUSES | 2004 |
|
RU2359999C2 |
| VACCINE AGAINST INFLUENZA TYPE A, INFLUENZA TYPE B AND COVID-19 | 2021 |
|
RU2751485C1 |
| MINUS-CHAIN-CONTAINING ATTENUATED VIRUSES WITH CHANGED ANTAGONISTIC ACTIVITY AS REGARDS FOR INTERFERON FOR APPLYING AS VACCINES AND PHARMACEUTICAL SUBSTANCES | 1999 |
|
RU2236252C2 |
| PHARMACEUTICAL COMPOSITION FOR PASSIVE RABIES IMMUNIZATION, PHARMACEUTICAL KIT, PHARMACEUTICAL KIT APPLICATION METHOD | 2016 |
|
RU2661028C2 |
| ANTIVIRAL SIMILAR MINI-ANTIBODY, NUCLEOTIDE SEQUENCE, EXPRESSING RECOMBINANT VIRAL VECTOR, PHARMACEUTICAL COMPOSITION AND METHOD FOR PREVENTION OR THERAPY OF INFLUENZA TYPE A | 2013 |
|
RU2536956C1 |
